High ROIC Stocks
WST is currently part of our High ROIC Stocks screen, indicating it generates strong returns on invested capital.
WEST PHARMACEUTICAL SERVICES (WST) Stock Price & Overview
NYSE:WST • US9553061055
Current stock price
250.64 USD
+5.5 (+2.24%)
At close:
250.64 USD
0 (0%)
After Hours:
The current stock price of WST is 250.64 USD. Today WST is up by 2.24%. In the past month the price decreased by -0.29%. In the past year, price increased by 23.34%.
WST Key Statistics
52-Week Range187.43 - 322.34
Current WST stock price positioned within its 52-week range.
1-Month Range228.4 - 254.605
Current WST stock price positioned within its 1-month range.
- Market Cap
- 18.066B
- P/E
- 34.38
- Fwd P/E
- 30.94
- EPS (TTM)
- 7.29
- Dividend Yield
- 0.32%
WST Stock Performance
Today
+2.24%
1 Week
+2.19%
1 Month
-0.29%
3 Months
-9.32%
Longer-term
6 Months -8.04%
1 Year +23.34%
2 Years -36.66%
3 Years -27.66%
5 Years -11.05%
10 Years +261.57%
WST Stock Chart
WST Stock Screens
WST currently appears in the following ChartMill screener lists.
WST Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to WST. When comparing the yearly performance of all stocks, WST turns out to be only a medium performer in the overall market: it outperformed 53.17% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
WST Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to WST. WST gets an excellent profitability rating and is at the same time showing great financial health properties.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
WST Earnings
On February 12, 2026 WST reported an EPS of 2.04 and a revenue of 805.00M. The company beat EPS expectations (10.24% surprise) and beat revenue expectations (0.33% surprise).
Next Earnings DateApr 23, 2026
Last Earnings DateFeb 12, 2026
PeriodQ4 / 2025
EPS Reported$2.04
Revenue Reported805M
EPS Surprise 10.24%
Revenue Surprise 0.33%
WST Forecast & Estimates
23 analysts have analysed WST and the average price target is 328.99 USD. This implies a price increase of 31.26% is expected in the next year compared to the current price of 250.64.
For the next year, analysts expect an EPS growth of 11.14% and a revenue growth 6.04% for WST
Analysts
Analysts80.87
Price Target328.99 (31.26%)
EPS Next Y11.14%
Revenue Next Year6.04%
WST Groups
Sector & Classification
Sector
Health Care Sub-Industry
Life Sciences Tools & Services WST Financial Highlights
Over the last trailing twelve months WST reported a non-GAAP Earnings per Share(EPS) of 7.29. The EPS increased by 8% compared to the year before.
Income Statements
Revenue(TTM)3.07B
Net Income(TTM)493.70M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.06% | ||
| ROA | 11.56% | ||
| ROE | 15.54% | ||
| Debt/Equity | 0.06 |
Chartmill High Growth Momentum
EPS Q2Q%12.09%
Sales Q2Q%7.51%
EPS 1Y (TTM)8%
Revenue 1Y (TTM)6.25%
WST Ownership
Ownership
Inst Owners97.62%
Shares72.08M
Float71.63M
Ins Owners0.33%
Short Float %3.58%
Short Ratio2.42
WST Competitors/Peers
The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.82 | 182.594B | ||
| DHR | DANAHER CORP | 22.33 | 134.074B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 130.61 | 42.964B | ||
| A | AGILENT TECHNOLOGIES INC | 17.04 | 32.211B | ||
| WAT | WATERS CORP | 20.49 | 29.214B | ||
| IQV | IQVIA HOLDINGS INC | 13.31 | 28.629B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.89 | 25.64B | ||
| ILMN | ILLUMINA INC | 23.56 | 18.847B | ||
| MEDP | MEDPACE HOLDINGS INC | 27.55 | 13.628B | ||
| RVTY | REVVITY INC | 15.89 | 9.795B | ||
| CRL | CHARLES RIVER LABORATORIES | 15.47 | 8.492B | ||
| TECH | BIO-TECHNE CORP | 23.49 | 8.176B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About WST
Company Profile
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,800 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Company Info
IPO: 1923-07-27
WEST PHARMACEUTICAL SERVICES
530 Herman O. West Drive
Exton PENNSYLVANIA 19341 US
CEO: Eric M. Green
Employees: 10800
Phone: 18006222300
WEST PHARMACEUTICAL SERVICES / WST FAQ
What does WST do?
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,800 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
What is the current price of WST stock?
The current stock price of WST is 250.64 USD. The price increased by 2.24% in the last trading session.
Does WEST PHARMACEUTICAL SERVICES pay dividends?
WEST PHARMACEUTICAL SERVICES (WST) has a dividend yield of 0.32%. The yearly dividend amount is currently 0.85.
What is the ChartMill technical and fundamental rating of WST stock?
WST has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the number of employees for WEST PHARMACEUTICAL SERVICES?
WEST PHARMACEUTICAL SERVICES (WST) currently has 10800 employees.
What is the market capitalization of WST stock?
WEST PHARMACEUTICAL SERVICES (WST) has a market capitalization of 18.07B USD. This makes WST a Large Cap stock.
Who owns WEST PHARMACEUTICAL SERVICES?
You can find the ownership structure of WEST PHARMACEUTICAL SERVICES (WST) on the Ownership tab.